FNWFX
Price
$80.67
Change
-$1.85 (-2.24%)
Updated
Dec 18 closing price
GIRMX
Price
$23.27
Change
-$0.35 (-1.48%)
Updated
Dec 18 closing price
Ad is loading...

FNWFX vs GIRMX

Header iconFNWFX vs GIRMX Comparison
Open Charts FNWFX vs GIRMXBanner chart's image
American Funds New World F3
Price$80.67
Change-$1.85 (-2.24%)
VolumeN/A
CapitalizationN/A
Goldman Sachs Emerging Markets Eq I
Price$23.27
Change-$0.35 (-1.48%)
VolumeN/A
CapitalizationN/A
FNWFX vs GIRMX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FNWFX vs. GIRMX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FNWFX is a Buy and GIRMX is a StrongSell.

FUNDAMENTALS
Fundamentals
FNWFX has more cash in the bank: 64B vs. GIRMX (2.75B). FNWFX pays higher dividends than GIRMX: FNWFX (1.56) vs GIRMX (1.21). FNWFX was incepted earlier than GIRMX: FNWFX (8 years) vs GIRMX (14 years). FNWFX (32.00) and GIRMX (32.00) have comparable annual turnover. GIRMX has a lower initial minimum investment than FNWFX: GIRMX (0) vs FNWFX (1000000). GIRMX annual gain was more profitable for investors over the last year : 14.49 vs. FNWFX (12.00). FNWFX return over 5 years is better than : 16.03 vs. GIRMX (6.45).
FNWFXGIRMXFNWFX / GIRMX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years14 years-
Gain YTD10.02711.60786%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets64B2.75B2,332%
Annual Yield % from dividends1.561.21129%
Returns for 1 year12.0014.4983%
Returns for 3 years0.71-15.53-5%
Returns for 5 years16.036.45249%
Returns for 10 yearsN/A56.21-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BRC75.93-0.76
-0.99%
Brady Corp
GEN29.38-0.35
-1.18%
Gen Digital
SACH1.24-0.03
-2.36%
Sachem Capital Corp
NN17.55-0.45
-2.50%
NextNav
CANF1.42-0.09
-5.96%
Can-Fite BioPharma Ltd